nodes	percent_of_prediction	percent_of_DWPC	metapath
Vancomycin—Muscle spasms—Etoposide—urinary bladder cancer	0.00169	0.00169	CcSEcCtD
Vancomycin—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.00168	0.00168	CcSEcCtD
Vancomycin—Infection—Gemcitabine—urinary bladder cancer	0.00167	0.00167	CcSEcCtD
Vancomycin—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.00166	0.00166	CcSEcCtD
Vancomycin—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.00165	0.00165	CcSEcCtD
Vancomycin—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.00165	0.00165	CcSEcCtD
Vancomycin—Infection—Fluorouracil—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Vancomycin—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Vancomycin—Skin disorder—Gemcitabine—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Vancomycin—Anaemia—Etoposide—urinary bladder cancer	0.00163	0.00163	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.00163	0.00163	CcSEcCtD
Vancomycin—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.00162	0.00162	CcSEcCtD
Vancomycin—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00162	0.00162	CcSEcCtD
Vancomycin—Tachycardia—Fluorouracil—urinary bladder cancer	0.00162	0.00162	CcSEcCtD
Vancomycin—Dermatitis exfoliative—Doxorubicin—urinary bladder cancer	0.00161	0.00161	CcSEcCtD
Vancomycin—Renal impairment—Doxorubicin—urinary bladder cancer	0.00159	0.00159	CcSEcCtD
Vancomycin—Urticaria—Thiotepa—urinary bladder cancer	0.00159	0.00159	CcSEcCtD
Vancomycin—Dermatitis bullous—Doxorubicin—urinary bladder cancer	0.00159	0.00159	CcSEcCtD
Vancomycin—Vertigo—Etoposide—urinary bladder cancer	0.00158	0.00158	CcSEcCtD
Vancomycin—Body temperature increased—Thiotepa—urinary bladder cancer	0.00158	0.00158	CcSEcCtD
Vancomycin—Abdominal pain—Thiotepa—urinary bladder cancer	0.00158	0.00158	CcSEcCtD
Vancomycin—Toxic epidermal necrolysis—Methotrexate—urinary bladder cancer	0.00158	0.00158	CcSEcCtD
Vancomycin—Hypotension—Gemcitabine—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Vancomycin—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Vancomycin—Anaphylactoid reaction—Doxorubicin—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Vancomycin—Infection—Cisplatin—urinary bladder cancer	0.00156	0.00156	CcSEcCtD
Vancomycin—Hypotension—Fluorouracil—urinary bladder cancer	0.00155	0.00155	CcSEcCtD
Vancomycin—Nervous system disorder—Cisplatin—urinary bladder cancer	0.00154	0.00154	CcSEcCtD
Vancomycin—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.00154	0.00154	CcSEcCtD
Vancomycin—Blood creatinine increased—Epirubicin—urinary bladder cancer	0.00154	0.00154	CcSEcCtD
Vancomycin—Tachycardia—Cisplatin—urinary bladder cancer	0.00153	0.00153	CcSEcCtD
Vancomycin—Skin disorder—Cisplatin—urinary bladder cancer	0.00152	0.00152	CcSEcCtD
Vancomycin—Insomnia—Gemcitabine—urinary bladder cancer	0.00152	0.00152	CcSEcCtD
Vancomycin—Dyspnoea—Gemcitabine—urinary bladder cancer	0.0015	0.0015	CcSEcCtD
Vancomycin—Eosinophilia—Methotrexate—urinary bladder cancer	0.0015	0.0015	CcSEcCtD
Vancomycin—Insomnia—Fluorouracil—urinary bladder cancer	0.0015	0.0015	CcSEcCtD
Vancomycin—Hypokalaemia—Epirubicin—urinary bladder cancer	0.00149	0.00149	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.00149	0.00149	CcSEcCtD
Vancomycin—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	0.00148	0.00148	CcSEcCtD
Vancomycin—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00148	0.00148	CcSEcCtD
Vancomycin—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00147	0.00147	CcSEcCtD
Vancomycin—Hypotension—Cisplatin—urinary bladder cancer	0.00147	0.00147	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Vancomycin—Fatigue—Gemcitabine—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Vancomycin—Constipation—Gemcitabine—urinary bladder cancer	0.00144	0.00144	CcSEcCtD
Vancomycin—Pain—Gemcitabine—urinary bladder cancer	0.00144	0.00144	CcSEcCtD
Vancomycin—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00144	0.00144	CcSEcCtD
Vancomycin—Asthenia—Thiotepa—urinary bladder cancer	0.00144	0.00144	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Vancomycin—Infection—Etoposide—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Vancomycin—Blood creatinine increased—Doxorubicin—urinary bladder cancer	0.00142	0.00142	CcSEcCtD
Vancomycin—Neutropenia—Methotrexate—urinary bladder cancer	0.00142	0.00142	CcSEcCtD
Vancomycin—Pruritus—Thiotepa—urinary bladder cancer	0.00142	0.00142	CcSEcCtD
Vancomycin—Pain—Fluorouracil—urinary bladder cancer	0.00142	0.00142	CcSEcCtD
Vancomycin—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00141	0.00141	CcSEcCtD
Vancomycin—Tachycardia—Etoposide—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Vancomycin—Eosinophilia—Epirubicin—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Vancomycin—Dyspnoea—Cisplatin—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Vancomycin—Skin disorder—Etoposide—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Vancomycin—Hypokalaemia—Doxorubicin—urinary bladder cancer	0.00138	0.00138	CcSEcCtD
Vancomycin—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.00137	0.00137	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Vancomycin—Infestation NOS—Methotrexate—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Vancomycin—Infestation—Methotrexate—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Vancomycin—Hypotension—Etoposide—urinary bladder cancer	0.00134	0.00134	CcSEcCtD
Vancomycin—Pain—Cisplatin—urinary bladder cancer	0.00134	0.00134	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.00134	0.00134	CcSEcCtD
Vancomycin—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Vancomycin—Renal failure—Methotrexate—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Vancomycin—Neutropenia—Epirubicin—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Vancomycin—Dizziness—Thiotepa—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Vancomycin—Urticaria—Fluorouracil—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Vancomycin—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Vancomycin—Eosinophilia—Doxorubicin—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Vancomycin—Dyspnoea—Etoposide—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Vancomycin—Vomiting—Thiotepa—urinary bladder cancer	0.00127	0.00127	CcSEcCtD
Vancomycin—Infestation—Epirubicin—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Vancomycin—Infestation NOS—Epirubicin—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Vancomycin—Rash—Thiotepa—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Vancomycin—Dermatitis—Thiotepa—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Vancomycin—Agranulocytosis—Methotrexate—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Vancomycin—Headache—Thiotepa—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Vancomycin—Renal failure—Epirubicin—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Vancomycin—Body temperature increased—Cisplatin—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Vancomycin—Fatigue—Etoposide—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Vancomycin—Pain—Etoposide—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Vancomycin—Constipation—Etoposide—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Vancomycin—Urinary tract infection—Epirubicin—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Vancomycin—Neutropenia—Doxorubicin—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Vancomycin—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Vancomycin—Asthenia—Gemcitabine—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Vancomycin—Pruritus—Gemcitabine—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Vancomycin—Nausea—Thiotepa—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Vancomycin—Agranulocytosis—Epirubicin—urinary bladder cancer	0.00118	0.00118	CcSEcCtD
Vancomycin—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00118	0.00118	CcSEcCtD
Vancomycin—Pruritus—Fluorouracil—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Vancomycin—Infestation NOS—Doxorubicin—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Vancomycin—Infestation—Doxorubicin—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Vancomycin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Vancomycin—Bradycardia—Epirubicin—urinary bladder cancer	0.00115	0.00115	CcSEcCtD
Vancomycin—Renal failure—Doxorubicin—urinary bladder cancer	0.00115	0.00115	CcSEcCtD
Vancomycin—Erythema multiforme—Methotrexate—urinary bladder cancer	0.00115	0.00115	CcSEcCtD
Vancomycin—Urticaria—Etoposide—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Vancomycin—Body temperature increased—Etoposide—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Vancomycin—Abdominal pain—Etoposide—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Vancomycin—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Vancomycin—Tinnitus—Methotrexate—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Vancomycin—Asthenia—Cisplatin—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Vancomycin—Oedema peripheral—Epirubicin—urinary bladder cancer	0.00112	0.00112	CcSEcCtD
Vancomycin—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Vancomycin—Dizziness—Fluorouracil—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Vancomycin—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Vancomycin—Chills—Methotrexate—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Vancomycin—Erythema multiforme—Epirubicin—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Vancomycin—Vomiting—Gemcitabine—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Vancomycin—Bradycardia—Doxorubicin—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Vancomycin—Rash—Gemcitabine—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Vancomycin—Dermatitis—Gemcitabine—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Vancomycin—Hypersensitivity—Etoposide—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Vancomycin—Tinnitus—Epirubicin—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Vancomycin—Erythema—Methotrexate—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Vancomycin—Malnutrition—Methotrexate—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Vancomycin—Headache—Gemcitabine—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Vancomycin—Flushing—Epirubicin—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Vancomycin—Vomiting—Fluorouracil—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Vancomycin—Rash—Fluorouracil—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Vancomycin—Dermatitis—Fluorouracil—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Vancomycin—Headache—Fluorouracil—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Vancomycin—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Vancomycin—Asthenia—Etoposide—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Vancomycin—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Vancomycin—Back pain—Methotrexate—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Vancomycin—Chills—Epirubicin—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Vancomycin—Pruritus—Etoposide—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Vancomycin—Nausea—Gemcitabine—urinary bladder cancer	0.001	0.001	CcSEcCtD
Vancomycin—Vomiting—Cisplatin—urinary bladder cancer	0.000998	0.000998	CcSEcCtD
Vancomycin—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000992	0.000992	CcSEcCtD
Vancomycin—Rash—Cisplatin—urinary bladder cancer	0.000989	0.000989	CcSEcCtD
Vancomycin—Dermatitis—Cisplatin—urinary bladder cancer	0.000988	0.000988	CcSEcCtD
Vancomycin—Erythema—Epirubicin—urinary bladder cancer	0.000987	0.000987	CcSEcCtD
Vancomycin—Malnutrition—Epirubicin—urinary bladder cancer	0.000987	0.000987	CcSEcCtD
Vancomycin—Nausea—Fluorouracil—urinary bladder cancer	0.000983	0.000983	CcSEcCtD
Vancomycin—Tinnitus—Doxorubicin—urinary bladder cancer	0.000978	0.000978	CcSEcCtD
Vancomycin—Anaemia—Methotrexate—urinary bladder cancer	0.000975	0.000975	CcSEcCtD
Vancomycin—Flushing—Doxorubicin—urinary bladder cancer	0.000974	0.000974	CcSEcCtD
Vancomycin—Flatulence—Epirubicin—urinary bladder cancer	0.000973	0.000973	CcSEcCtD
Vancomycin—Back pain—Epirubicin—urinary bladder cancer	0.000955	0.000955	CcSEcCtD
Vancomycin—Dizziness—Etoposide—urinary bladder cancer	0.000951	0.000951	CcSEcCtD
Vancomycin—Muscle spasms—Epirubicin—urinary bladder cancer	0.000949	0.000949	CcSEcCtD
Vancomycin—Vertigo—Methotrexate—urinary bladder cancer	0.000948	0.000948	CcSEcCtD
Vancomycin—Chills—Doxorubicin—urinary bladder cancer	0.000942	0.000942	CcSEcCtD
Vancomycin—Nausea—Cisplatin—urinary bladder cancer	0.000932	0.000932	CcSEcCtD
Vancomycin—Vomiting—Etoposide—urinary bladder cancer	0.000914	0.000914	CcSEcCtD
Vancomycin—Erythema—Doxorubicin—urinary bladder cancer	0.000914	0.000914	CcSEcCtD
Vancomycin—Malnutrition—Doxorubicin—urinary bladder cancer	0.000914	0.000914	CcSEcCtD
Vancomycin—Anaemia—Epirubicin—urinary bladder cancer	0.000913	0.000913	CcSEcCtD
Vancomycin—Rash—Etoposide—urinary bladder cancer	0.000906	0.000906	CcSEcCtD
Vancomycin—Dermatitis—Etoposide—urinary bladder cancer	0.000906	0.000906	CcSEcCtD
Vancomycin—Headache—Etoposide—urinary bladder cancer	0.000901	0.000901	CcSEcCtD
Vancomycin—Flatulence—Doxorubicin—urinary bladder cancer	0.0009	0.0009	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000892	0.000892	CcSEcCtD
Vancomycin—Vertigo—Epirubicin—urinary bladder cancer	0.000887	0.000887	CcSEcCtD
Vancomycin—Back pain—Doxorubicin—urinary bladder cancer	0.000884	0.000884	CcSEcCtD
Vancomycin—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000878	0.000878	CcSEcCtD
Vancomycin—Palpitations—Epirubicin—urinary bladder cancer	0.000873	0.000873	CcSEcCtD
Vancomycin—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000861	0.000861	CcSEcCtD
Vancomycin—Infection—Methotrexate—urinary bladder cancer	0.000855	0.000855	CcSEcCtD
Vancomycin—Nausea—Etoposide—urinary bladder cancer	0.000854	0.000854	CcSEcCtD
Vancomycin—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000844	0.000844	CcSEcCtD
Vancomycin—Anaemia—Doxorubicin—urinary bladder cancer	0.000844	0.000844	CcSEcCtD
Vancomycin—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000843	0.000843	CcSEcCtD
Vancomycin—Skin disorder—Methotrexate—urinary bladder cancer	0.000836	0.000836	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000835	0.000835	CcSEcCtD
Vancomycin—Vertigo—Doxorubicin—urinary bladder cancer	0.000821	0.000821	CcSEcCtD
Vancomycin—Palpitations—Doxorubicin—urinary bladder cancer	0.000807	0.000807	CcSEcCtD
Vancomycin—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000806	0.000806	CcSEcCtD
Vancomycin—Hypotension—Methotrexate—urinary bladder cancer	0.000805	0.000805	CcSEcCtD
Vancomycin—Infection—Epirubicin—urinary bladder cancer	0.000801	0.000801	CcSEcCtD
Vancomycin—Nervous system disorder—Epirubicin—urinary bladder cancer	0.00079	0.00079	CcSEcCtD
Vancomycin—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000789	0.000789	CcSEcCtD
Vancomycin—Tachycardia—Epirubicin—urinary bladder cancer	0.000786	0.000786	CcSEcCtD
Vancomycin—Skin disorder—Epirubicin—urinary bladder cancer	0.000783	0.000783	CcSEcCtD
Vancomycin—Insomnia—Methotrexate—urinary bladder cancer	0.000779	0.000779	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000772	0.000772	CcSEcCtD
Vancomycin—Dyspnoea—Methotrexate—urinary bladder cancer	0.000768	0.000768	CcSEcCtD
Vancomycin—Hypotension—Epirubicin—urinary bladder cancer	0.000753	0.000753	CcSEcCtD
Vancomycin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000746	0.000746	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000743	0.000743	CcSEcCtD
Vancomycin—Fatigue—Methotrexate—urinary bladder cancer	0.000742	0.000742	CcSEcCtD
Vancomycin—Infection—Doxorubicin—urinary bladder cancer	0.000741	0.000741	CcSEcCtD
Vancomycin—Pain—Methotrexate—urinary bladder cancer	0.000736	0.000736	CcSEcCtD
Vancomycin—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000731	0.000731	CcSEcCtD
Vancomycin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.00073	0.00073	CcSEcCtD
Vancomycin—Insomnia—Epirubicin—urinary bladder cancer	0.000729	0.000729	CcSEcCtD
Vancomycin—Tachycardia—Doxorubicin—urinary bladder cancer	0.000728	0.000728	CcSEcCtD
Vancomycin—Skin disorder—Doxorubicin—urinary bladder cancer	0.000724	0.000724	CcSEcCtD
Vancomycin—Dyspnoea—Epirubicin—urinary bladder cancer	0.000718	0.000718	CcSEcCtD
Vancomycin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000704	0.000704	CcSEcCtD
Vancomycin—Hypotension—Doxorubicin—urinary bladder cancer	0.000697	0.000697	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000696	0.000696	CcSEcCtD
Vancomycin—Fatigue—Epirubicin—urinary bladder cancer	0.000695	0.000695	CcSEcCtD
Vancomycin—Pain—Epirubicin—urinary bladder cancer	0.000689	0.000689	CcSEcCtD
Vancomycin—Constipation—Epirubicin—urinary bladder cancer	0.000689	0.000689	CcSEcCtD
Vancomycin—Urticaria—Methotrexate—urinary bladder cancer	0.000684	0.000684	CcSEcCtD
Vancomycin—Abdominal pain—Methotrexate—urinary bladder cancer	0.000681	0.000681	CcSEcCtD
Vancomycin—Body temperature increased—Methotrexate—urinary bladder cancer	0.000681	0.000681	CcSEcCtD
Vancomycin—Insomnia—Doxorubicin—urinary bladder cancer	0.000674	0.000674	CcSEcCtD
Vancomycin—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000665	0.000665	CcSEcCtD
Vancomycin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000659	0.000659	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000644	0.000644	CcSEcCtD
Vancomycin—Fatigue—Doxorubicin—urinary bladder cancer	0.000643	0.000643	CcSEcCtD
Vancomycin—Urticaria—Epirubicin—urinary bladder cancer	0.00064	0.00064	CcSEcCtD
Vancomycin—Pain—Doxorubicin—urinary bladder cancer	0.000638	0.000638	CcSEcCtD
Vancomycin—Constipation—Doxorubicin—urinary bladder cancer	0.000638	0.000638	CcSEcCtD
Vancomycin—Abdominal pain—Epirubicin—urinary bladder cancer	0.000637	0.000637	CcSEcCtD
Vancomycin—Body temperature increased—Epirubicin—urinary bladder cancer	0.000637	0.000637	CcSEcCtD
Vancomycin—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000634	0.000634	CcSEcCtD
Vancomycin—Asthenia—Methotrexate—urinary bladder cancer	0.000618	0.000618	CcSEcCtD
Vancomycin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.00061	0.00061	CcSEcCtD
Vancomycin—Pruritus—Methotrexate—urinary bladder cancer	0.000609	0.000609	CcSEcCtD
Vancomycin—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000594	0.000594	CcSEcCtD
Vancomycin—Urticaria—Doxorubicin—urinary bladder cancer	0.000592	0.000592	CcSEcCtD
Vancomycin—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000589	0.000589	CcSEcCtD
Vancomycin—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000589	0.000589	CcSEcCtD
Vancomycin—Asthenia—Epirubicin—urinary bladder cancer	0.000578	0.000578	CcSEcCtD
Vancomycin—Pruritus—Epirubicin—urinary bladder cancer	0.00057	0.00057	CcSEcCtD
Vancomycin—Dizziness—Methotrexate—urinary bladder cancer	0.000569	0.000569	CcSEcCtD
Vancomycin—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000549	0.000549	CcSEcCtD
Vancomycin—Vomiting—Methotrexate—urinary bladder cancer	0.000547	0.000547	CcSEcCtD
Vancomycin—Rash—Methotrexate—urinary bladder cancer	0.000543	0.000543	CcSEcCtD
Vancomycin—Dermatitis—Methotrexate—urinary bladder cancer	0.000542	0.000542	CcSEcCtD
Vancomycin—Headache—Methotrexate—urinary bladder cancer	0.000539	0.000539	CcSEcCtD
Vancomycin—Asthenia—Doxorubicin—urinary bladder cancer	0.000535	0.000535	CcSEcCtD
Vancomycin—Dizziness—Epirubicin—urinary bladder cancer	0.000533	0.000533	CcSEcCtD
Vancomycin—Pruritus—Doxorubicin—urinary bladder cancer	0.000527	0.000527	CcSEcCtD
Vancomycin—Vomiting—Epirubicin—urinary bladder cancer	0.000512	0.000512	CcSEcCtD
Vancomycin—Nausea—Methotrexate—urinary bladder cancer	0.000511	0.000511	CcSEcCtD
Vancomycin—Rash—Epirubicin—urinary bladder cancer	0.000508	0.000508	CcSEcCtD
Vancomycin—Dermatitis—Epirubicin—urinary bladder cancer	0.000508	0.000508	CcSEcCtD
Vancomycin—Headache—Epirubicin—urinary bladder cancer	0.000505	0.000505	CcSEcCtD
Vancomycin—Dizziness—Doxorubicin—urinary bladder cancer	0.000493	0.000493	CcSEcCtD
Vancomycin—Nausea—Epirubicin—urinary bladder cancer	0.000479	0.000479	CcSEcCtD
Vancomycin—Vomiting—Doxorubicin—urinary bladder cancer	0.000474	0.000474	CcSEcCtD
Vancomycin—Rash—Doxorubicin—urinary bladder cancer	0.00047	0.00047	CcSEcCtD
Vancomycin—Dermatitis—Doxorubicin—urinary bladder cancer	0.00047	0.00047	CcSEcCtD
Vancomycin—Headache—Doxorubicin—urinary bladder cancer	0.000467	0.000467	CcSEcCtD
Vancomycin—Nausea—Doxorubicin—urinary bladder cancer	0.000443	0.000443	CcSEcCtD
